The effect of apolipoprotein E (ApoE) genotype on biomarkers of amyloidogenesis, tau pathology and neurodegeneration in Alzheimer's disease.
about
APOE -ε4 allele for the diagnosis of Alzheimer's and other dementia disorders in people with mild cognitive impairment in a community settingAPOE -ε4 allele for the diagnosis of Alzheimer's and other dementia disorders in people with mild cognitive impairment in a secondary care settingAPOE -ε4 allele for the diagnosis of Alzheimer's and other dementia disorders in people with mild cognitive impairment in a primary care settingDisrupted structural and functional brain connectomes in mild cognitive impairment and Alzheimer's disease.Interaction between sleep-disordered breathing and apolipoprotein E genotype on cerebrospinal fluid biomarkers for Alzheimer's disease in cognitively normal elderly individuals.Soluble amyloid-β levels and late-life depressionAmyloid-β pathology and APOE genotype modulate retinoid X receptor agonist activity in vivo.BioAge: toward a multi-determined, mechanistic account of cognitive aging.APOE4 enhances age-dependent decline in cognitive function by down-regulating an NMDA receptor pathway in EFAD-Tg mice.Follow-up plasma apolipoprotein E levels in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL) cohort.On the translocation of bacteria and their lipopolysaccharides between blood and peripheral locations in chronic, inflammatory diseases: the central roles of LPS and LPS-induced cell death.The nitric oxide synthase 3 G894T polymorphism associated with Alzheimer's disease risk: a meta-analysis.Influence of APOE Genotype on Alzheimer's Disease CSF Biomarkers in a Spanish PopulationApolipoprotein E gene polymorphism in a Chinese population with vascular dementia: a meta-analysis.Relationship between genetic risk factors and markers for Alzheimer's disease pathology.Combination of Aβ clearance and neurotrophic factors as a potential treatment for Alzheimer's disease.Vascular endothelial growth factor gene promoter polymorphisms and Alzheimer's disease risk: a meta-analysis.Soluble apoE/Aβ complex: mechanism and therapeutic target for APOE4-induced AD risk.The complex genetics in autism spectrum disorders.EFAD transgenic mice as a human APOE relevant preclinical model of Alzheimer's disease.Biomarkers for the Early Detection and Progression of Alzheimer's Disease.Network Diffusion Model of Progression Predicts Longitudinal Patterns of Atrophy and Metabolism in Alzheimer's Disease.Alzheimer's Disease: Biomarkers in the Genome, Blood, and Cerebrospinal Fluid.Vascular Health and Genetic Risk Affect Mild Cognitive Impairment Status and 4-Year Stability: Evidence From the Victoria Longitudinal Study.Peripheral Inflammation, Apolipoprotein E4, and Amyloid-β Interact to Induce Cognitive and Cerebrovascular Dysfunction.Association between Polymorphisms of the AKT1 Gene Promoter and Risk of the Alzheimer's Disease in a Chinese Han Population with Type 2 Diabetes.Serum granulocyte colony-stimulating factor and Alzheimer's disease.High apolipoprotein E4 allele frequency in FXTAS patients.Impact of amyloid-beta changes on cognitive outcomes in Alzheimer's disease: analysis of clinical trials using a quantitative systems pharmacology model.ApoE type 4 allele affects cognitive function of aged population in Tianjin City, China.Infection of Fungi and Bacteria in Brain Tissue From Elderly Persons and Patients With Alzheimer's Disease.Controlling for confounding factors and revealing their interactions in genetic association meta-analyses: a computing method and application for stratification analyses.
P2860
Q24201260-433BB549-49D0-4224-A643-C7758BE5CF5DQ24201265-1D967F5A-ED49-49BD-8DB8-FD1A4E47F30FQ24201271-AAAB9A44-A711-4996-926C-8EC75E9C47D3Q30801104-4F520610-9153-446A-AC83-8651D772D973Q33616238-4E471019-80AB-413D-90E0-85D13E9E82F1Q33933220-1DB0DBFE-8FE3-4498-812A-0B10F6A3B224Q34431008-6BFF353F-97FC-46BC-8AB1-73F28011D865Q34644175-A20489F4-1BC5-4D5E-8B46-1CCFFC836FBEQ35337169-16699799-7D32-406A-9BD2-56CE2B600E40Q35342893-C984CA9A-68AC-42F8-9199-F50D4150180EQ35765830-0887CE21-C55E-4007-93A1-D89B041D6371Q36026924-59FE6B19-9E38-4A68-9AA5-1851F2CA2AF0Q36764582-E27FD58B-3C54-4406-A760-935D4E8F416FQ37995441-CA824E0B-807B-4B2F-9986-FFD47DC56316Q38037159-3D93086E-3E3B-418B-B52E-D68E9BC719E3Q38062334-16E1683E-06AF-4FDC-8368-BAEAB7F90D4AQ38098046-9B9C7F41-BDA8-4ECF-AFA0-EF063F69CB78Q38175420-C99DAA60-9995-46A1-9C82-928C70D11C9DQ38579867-817D7EFE-47CF-496E-A7F5-24BC776F76B0Q38733357-FEC87FC9-48EF-4710-8771-60CB79701232Q38979999-B286C61D-45A2-4213-8403-465039346339Q39054090-E3997B7E-741F-4C41-8A1C-6F6EE71C27E6Q39217840-994E230B-C2B9-4B76-98A4-F224AED254F3Q40547409-EE1FD292-D1A2-40F9-AE11-1F6596F547D9Q41087339-6472739C-DA43-4C55-8E46-6D468730A043Q41583234-D68B2708-EF16-42B6-B9FE-2DE278E6027DQ41903809-3B088755-FA32-4663-9BFB-307F75225321Q45106065-707D3418-2FCB-469F-BCC8-8BCE69AF40E5Q48113629-16562DD5-A7D2-4885-91AE-12F06EF8E7E0Q50601685-9A3B8D6E-DE21-40C9-ADF8-EA88451F2212Q55017301-2A2771A2-7763-456F-8E79-2D7207DFE3B7Q55342019-55D85CD0-216F-4A92-89DB-F4A397F9DE8C
P2860
The effect of apolipoprotein E (ApoE) genotype on biomarkers of amyloidogenesis, tau pathology and neurodegeneration in Alzheimer's disease.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The effect of apolipoprotein E ...... ration in Alzheimer's disease.
@ast
The effect of apolipoprotein E ...... ration in Alzheimer's disease.
@en
type
label
The effect of apolipoprotein E ...... ration in Alzheimer's disease.
@ast
The effect of apolipoprotein E ...... ration in Alzheimer's disease.
@en
prefLabel
The effect of apolipoprotein E ...... ration in Alzheimer's disease.
@ast
The effect of apolipoprotein E ...... ration in Alzheimer's disease.
@en
P2860
P356
P1476
The effect of apolipoprotein E ...... ration in Alzheimer's disease.
@en
P2093
Valerio Leoni
P2860
P304
P356
10.1515/CCLM.2011.088
P577
2011-03-01T00:00:00Z